Infliximab therapeutic drug monitoring ( DrugBank: Infliximab )


2 diseases
IDDisease name (Link within this page)Number of trials
96Crohn disease1
97Ulcerative colitis1

96. Crohn disease


Clinical trials : 2,400 Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04775732
(ClinicalTrials.gov)
June 1, 201825/2/2021Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel DiseaseUltra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point-of-care-testing in Inflammatory Bowel Disease: a Pragmatic TrialCrohn Disease;Ulcerative ColitisBiological: infliximab therapeutic drug monitoringImelda GI Clinical Research CenterNULLCompletedN/AN/AAll187Phase 4Belgium

97. Ulcerative colitis


Clinical trials : 2,527 Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04775732
(ClinicalTrials.gov)
June 1, 201825/2/2021Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel DiseaseUltra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point-of-care-testing in Inflammatory Bowel Disease: a Pragmatic TrialCrohn Disease;Ulcerative ColitisBiological: infliximab therapeutic drug monitoringImelda GI Clinical Research CenterNULLCompletedN/AN/AAll187Phase 4Belgium